Annual EBITDA
-$92.64 M
-$16.26 M-21.29%
31 December 2023
Summary:
Cellectis SA annual earnings before interest, taxes, depreciation & amortization is currently -$92.64 million, with the most recent change of -$16.26 million (-21.29%) on 31 December 2023. During the last 3 years, it has fallen by -$49.30 million (-113.74%). CLLS annual EBITDA is now -2351.84% below its all-time high of $4.11 million, reached on 31 December 2014.CLLS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$16.48 M
+$2.42 M+12.83%
30 September 2024
Summary:
Cellectis SA quarterly earnings before interest, taxes, depreciation & amortization is currently -$16.48 million, with the most recent change of +$2.42 million (+12.83%) on 30 September 2024. Over the past year, it has dropped by -$5.08 million (-44.52%). CLLS quarterly EBITDA is now -182.21% below its all-time high of $20.04 million, reached on 01 March 2020.CLLS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$58.52 M
-$5.08 M-9.50%
30 September 2024
Summary:
Cellectis SA TTM earnings before interest, taxes, depreciation & amortization is currently -$58.52 million, with the most recent change of -$5.08 million (-9.50%) on 30 September 2024. Over the past year, it has increased by +$19.12 million (+24.63%). CLLS TTM EBITDA is now -1573.52% below its all-time high of -$3.50 million, reached on 01 March 2015.CLLS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLLS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.3% | -44.5% | +24.6% |
| 3 y3 years | -113.7% | +56.6% | +35.7% |
| 5 y5 years | -7.8% | +33.9% | +42.9% |
CLLS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -113.7% | at low | -240.3% | +56.6% | -9.5% | +37.4% |
| 5 y | 5 years | -113.7% | +12.4% | -182.2% | +58.4% | -26.9% | +48.3% |
| alltime | all time | -2351.8% | +12.4% | -182.2% | +58.4% | -1573.5% | +48.3% |
Cellectis SA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.48 M(-12.8%) | -$58.52 M(+9.5%) |
| June 2024 | - | -$18.90 M(-261.0%) | -$53.44 M(-8.2%) |
| Mar 2024 | - | $11.74 M(-133.7%) | -$58.24 M(-37.0%) |
| Dec 2023 | -$92.64 M(+21.3%) | -$34.88 M(+206.0%) | -$92.45 M(+19.1%) |
| Sept 2023 | - | -$11.40 M(-51.9%) | -$77.64 M(-10.3%) |
| June 2023 | - | -$23.70 M(+5.4%) | -$86.55 M(+13.3%) |
| Mar 2023 | - | -$22.47 M(+12.0%) | -$76.39 M(+0.5%) |
| Dec 2022 | -$76.38 M(-2.6%) | -$20.07 M(-1.2%) | -$75.97 M(+37.5%) |
| Sept 2022 | - | -$20.31 M(+50.0%) | -$55.26 M(-24.3%) |
| June 2022 | - | -$13.54 M(-38.6%) | -$72.94 M(-22.0%) |
| Mar 2022 | - | -$22.06 M(-3477.8%) | -$93.48 M(+14.2%) |
| Dec 2021 | -$78.42 M(+80.9%) | $653.00 K(-101.7%) | -$81.86 M(-10.1%) |
| Sept 2021 | - | -$38.00 M(+11.5%) | -$91.02 M(+14.1%) |
| June 2021 | - | -$34.07 M(+226.3%) | -$79.80 M(+4.2%) |
| Mar 2021 | - | -$10.44 M(+22.8%) | -$76.61 M(+66.1%) |
| Dec 2020 | -$43.34 M(-59.0%) | -$8.50 M(-68.3%) | -$46.13 M(-40.3%) |
| Sept 2020 | - | -$26.78 M(-13.3%) | -$77.27 M(+2.5%) |
| June 2020 | - | -$30.89 M(-254.1%) | -$75.41 M(-3.3%) |
| Mar 2020 | - | $20.04 M(-150.6%) | -$77.96 M(-31.1%) |
| Dec 2019 | -$105.73 M(+23.1%) | -$39.64 M(+59.0%) | -$113.19 M(+10.5%) |
| Sept 2019 | - | -$24.93 M(-25.5%) | -$102.40 M(-3.3%) |
| June 2019 | - | -$33.44 M(+120.1%) | -$105.90 M(+13.2%) |
| Mar 2019 | - | -$15.19 M(-47.3%) | -$93.53 M(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$85.91 M(-14.4%) | -$28.84 M(+1.4%) | -$102.61 M(-7.5%) |
| Sept 2018 | - | -$28.43 M(+35.0%) | -$110.96 M(+3.2%) |
| June 2018 | - | -$21.06 M(-13.2%) | -$107.55 M(+1.8%) |
| Mar 2018 | - | -$24.27 M(-34.7%) | -$105.68 M(+8.3%) |
| Dec 2017 | -$100.31 M(+54.2%) | -$37.20 M(+48.7%) | -$97.58 M(+21.7%) |
| Sept 2017 | - | -$25.02 M(+30.4%) | -$80.19 M(+18.8%) |
| June 2017 | - | -$19.19 M(+18.7%) | -$67.49 M(+14.5%) |
| Mar 2017 | - | -$16.17 M(-18.4%) | -$58.94 M(-8.4%) |
| Dec 2016 | -$65.03 M(+215.0%) | -$19.82 M(+60.9%) | -$64.33 M(+90.5%) |
| Sept 2016 | - | -$12.31 M(+15.6%) | -$33.77 M(-6.4%) |
| June 2016 | - | -$10.65 M(-50.6%) | -$36.08 M(-6.3%) |
| Mar 2016 | - | -$21.56 M(-300.5%) | -$38.51 M(+88.3%) |
| Dec 2015 | -$20.64 M(-601.8%) | $10.75 M(-173.5%) | -$20.45 M(-34.5%) |
| Sept 2015 | - | -$14.62 M(+11.8%) | -$31.20 M(+88.2%) |
| June 2015 | - | -$13.08 M(+274.2%) | -$16.58 M(+374.2%) |
| Mar 2015 | - | -$3.50 M | -$3.50 M |
| Dec 2014 | $4.11 M(-112.3%) | - | - |
| Dec 2013 | -$33.54 M(+61.6%) | - | - |
| Dec 2012 | -$20.76 M(-18.0%) | - | - |
| Dec 2011 | -$25.31 M(+72.2%) | - | - |
| Dec 2010 | -$14.70 M(+20.0%) | - | - |
| Dec 2009 | -$12.25 M(+283.0%) | - | - |
| Dec 2008 | -$3.20 M(-47.5%) | - | - |
| Dec 2007 | -$6.09 M | - | - |
FAQ
- What is Cellectis SA annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cellectis SA?
- What is Cellectis SA annual EBITDA year-on-year change?
- What is Cellectis SA quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cellectis SA?
- What is Cellectis SA quarterly EBITDA year-on-year change?
- What is Cellectis SA TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cellectis SA?
- What is Cellectis SA TTM EBITDA year-on-year change?
What is Cellectis SA annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CLLS is -$92.64 M
What is the all time high annual EBITDA for Cellectis SA?
Cellectis SA all-time high annual earnings before interest, taxes, depreciation & amortization is $4.11 M
What is Cellectis SA annual EBITDA year-on-year change?
Over the past year, CLLS annual earnings before interest, taxes, depreciation & amortization has changed by -$16.26 M (-21.29%)
What is Cellectis SA quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CLLS is -$16.48 M
What is the all time high quarterly EBITDA for Cellectis SA?
Cellectis SA all-time high quarterly earnings before interest, taxes, depreciation & amortization is $20.04 M
What is Cellectis SA quarterly EBITDA year-on-year change?
Over the past year, CLLS quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.08 M (-44.52%)
What is Cellectis SA TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CLLS is -$58.52 M
What is the all time high TTM EBITDA for Cellectis SA?
Cellectis SA all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.50 M
What is Cellectis SA TTM EBITDA year-on-year change?
Over the past year, CLLS TTM earnings before interest, taxes, depreciation & amortization has changed by +$19.12 M (+24.63%)